Joinn Laboratories(China)Co.,Ltd. (HKG:6127)
Hong Kong · Delayed Price · Currency is HKD 21.44
+0.68 (3.28%)
Oct 31, 2025, 4:08 PM HKT
HKG:6127 Market Cap
HKG:6127 has a market cap or net worth of 27.62 billion as of October 31, 2025. Its market cap has increased by 103.02% in one year.
Market Cap
27.62B
Enterprise Value
24.92B
Revenue
1.82B
Ranking
n/a
PE Ratio
112.26
Stock Price
21.44
Market Cap Chart
Since August 25, 2017, HKG:6127's market cap has increased from 1.73B to 27.62B, an increase of 1,492.03%. That is a compound annual growth rate of 40.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 27.62B | 128.17% |
| Dec 31, 2024 | 12.10B | -32.65% |
| Dec 29, 2023 | 17.97B | -45.80% |
| Dec 30, 2022 | 33.16B | -32.89% |
| Dec 31, 2021 | 49.40B | 77.37% |
| Dec 31, 2020 | 27.85B | 166.37% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 25, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 269.34B |
| Hansoh Pharmaceutical Group Company | 209.22B |
| JD Health International | 199.13B |
| WuXi Biologics | 149.43B |
| Innovent Biologics | 144.96B |
| Sino Biopharmaceutical | 125.85B |
| Akeso | 105.01B |
| Sichuan Kelun-Biotech Biopharmaceutical | 98.31B |